FDA Approves CAPECITABINE — Lifestar Pharma LLC

**TEXT:** Lifestar Pharma LLC received FDA approval for its Abbreviated New Drug Application for Oral Capecitabine under #ANDA211724. Market analysts expect this approval to intensify price competition and pressure the sales of existing branded formulations.